Publication | Closed Access

Treatment of HIV-1-Associated Kaposi’s Sarcoma with Pegylated Liposomal Doxorubicin and HAART Simultaneously Induces Effective Tumor Remission and CD4+ T Cell Recovery

Pegylated Liposomal DoxorubicinHuman RetrovirusImmunologyAntiviral ResponseT Cell ImmunityCd4 T Cell ResponsesHiv-1-associated Kaposi ’HivImmunotherapyMedicineRadiation Oncology